Absorbable Surgical Suture with Needle Market

Absorbable Surgical Suture with Needle Market Size, Market Forecast and Outlook By FMI

The absorbable surgical suture with needle market was valued at USD 490.30 million in 2025, projected to reach USD 524.13 million in 2026, and is forecast to expand to USD 1,021.45 million by 2036 at a 6.9% CAGR. FMI is of the opinion that the needle-suture combination product segment is gaining procurement share over separately packaged suture and needle components because pre-assembled configurations reduce operating room preparation time, minimize sharps handling risk, and enable standardized inventory management. Hospital materials managers increasingly specify needle-suture combination products as the default wound closure format across surgical departments.

Summary of Absorbable Surgical Suture with Needle Market

• Market Snapshot
  • The absorbable surgical suture with needle market is valued at USD 490.30 million in 2025 and is projected to reach USD 1,021.45 million by 2036.
  • The industry is expected to grow at a 6.9% CAGR from 2026 to 2036, creating an incremental opportunity of USD 497.32 million.
  • The market is a procedure-volume-driven, specification-intensive surgical consumables category where needle geometry, suture material, absorption timeline, and pre-assembled packaging efficiency define competitive positioning.
• Demand and Growth Drivers
  • Demand is rising as hospital procurement systems standardize on pre-assembled needle-suture combination products to reduce operating room preparation time and sharps handling risk.
  • Barbed suture technology is gaining adoption in laparoscopic and cosmetic procedures where knot-free closure reduces operative time.
  • Growth is further supported by the progressive displacement of non-absorbable wound closure by absorbable alternatives across expanding surgical indications.
  • Among key countries, India leads at 8.6% CAGR, followed by Germany at 7.9%, Brazil at 7.2%, the USA at 6.6%, the UK at 5.9%, and Japan at 5.2%.
• Product and Segment View
  • The market includes monofilament, braided, barbed, and specialty absorbable sutures pre-assembled with cutting, tapered, reverse cutting, and specialized surgical needles across multiple polymer compositions.
  • Monofilament sutures lead by product type with 52.3% share in 2026, driven by smooth tissue passage and reduced infection risk.
  • Hospital procedures lead by application with 41.7% share in 2026.
  • Material compositions include polyglycolic acid, polylactic acid, polyglactin, polydioxanone, and composite materials, each offering distinct absorption timelines.
  • The scope includes all pre-assembled absorbable suture-needle combination products, while excluding separately packaged sutures, non-absorbable needle-suture products, surgical stapling devices, and tissue adhesives.
• Geography and Competitive Outlook
  • India and Germany are the fastest-growing markets due to hospital infrastructure expansion and surgical supply chain modernization, while the United States remains the largest single-country market by value.
  • Competition is shaped by needle engineering precision, suture polymer portfolio breadth, and pre-assembled packaging efficiency, with key players including Johnson & Johnson, Ethicon LLC, Medtronic, B. Braun, and Boston Scientific.
  • As per FMI, the market is transitioning toward integrated wound closure kits that bundle multiple needle-suture configurations for specific procedure types.
• Analyst Opinion at FMI
  • Sabyasachi Ghosh, Principal Consultant for Healthcare Consumables, opines: 'In my analysis, I have observed that the critical differentiator in absorbable suture-needle procurement is no longer the suture material alone but the precision of the needle-suture attachment and the consistency of needle geometry across production lots. Surgeons who experience needle point deflection or suture separation during critical tissue approximation steps lose confidence in the product line and drive formulary switches that cost manufacturers multi-year contract positions. Quality assurance teams that treat needle-suture attachment testing as a secondary specification rather than a primary release criterion face disproportionate commercial risk.'
• Strategic Implications / Executive Takeaways
  • Suture manufacturers must invest in needle attachment engineering and lot-to-lot consistency testing to maintain surgeon confidence and protect group purchasing organization contract positions.
  • Hospital procurement directors should evaluate needle-suture combination products on total procedure cost metrics including operative time savings and sharps handling risk reduction rather than unit price alone.
  • Surgical department heads must assess barbed suture adoption for laparoscopic and cosmetic procedures where knot-free closure can reduce operative time by 15 to 25 percent.

Absorbable Surgical Suture with Needle Market Key Takeaways

Metric	Details
Industry Size (2026)	USD 524.13 million
Industry Value (2036)	USD 1,021.45 million
CAGR (2026-2036)	6.9%

Source: Future Market Insights, 2026

The market is adding an incremental opportunity of approximately USD 497.32 million between 2026 and 2036. This growth reflects the convergence of rising global surgical volumes, expanding outpatient surgical center capacity, and the progressive displacement of non-absorbable wound closure by absorbable alternatives across an expanding range of surgical indications. Barbed suture technology, which eliminates the need for surgical knot tying by anchoring tissue along the suture length, is gaining adoption in laparoscopic and cosmetic procedures where knot-free closure reduces operative time and improves wound tension distribution.

Regional growth trajectories reflect the geographic distribution of surgical infrastructure and wound closure procurement modernization. India sets the pace with an 8.6% CAGR, driven by hospital construction under the Ayushman Bharat Health Infrastructure Mission and growing adoption of pre-assembled suture-needle products across government hospital procurement systems. Germany follows at 7.9%, supported by its ambulatory surgery expansion and DIN-compliant surgical supply chain standards. Brazil registers a 7.2% pace, anchored by SUS surgical network expansion in secondary care facilities. The United States advances at 6.6%, driven by group purchasing organization contract transitions toward needle-suture combination products. The United Kingdom grows at 5.9%, while Japan registers a 5.2% trajectory.

Absorbable Surgical Suture with Needle Market Definition

Absorbable surgical sutures with needle are pre-assembled wound closure devices that combine an absorbable polymer suture strand with a permanently attached surgical needle. These products eliminate the need for separate needle threading, reduce operating room preparation time, and provide consistent needle-suture interface strength. Available across monofilament, braided, and barbed configurations in multiple polymer compositions and needle geometries.

Absorbable Surgical Suture with Needle Market Inclusions

Market scope includes all pre-assembled absorbable suture-needle combination products across monofilament, braided, barbed, and specialty configurations. Multiple polymer compositions (PGA, PLA, polyglactin, PDO, composites) and needle types (cutting, tapered, reverse cutting, specialized) are fully incorporated. Global and regional market sizes and segment-level analysis are covered.

Absorbable Surgical Suture with Needle Market Exclusions

Separately packaged sutures sold without pre-attached needles, non-absorbable needle-suture products, surgical stapling devices, tissue adhesives, wound closure strips, and surgical mesh products are excluded from this valuation.

Absorbable Surgical Suture with Needle Market Research Methodology

• Primary Research: Analysts engaged with operating room directors, surgical supply chain managers, group purchasing organization formulary committees, and suture manufacturing executives to map procurement decision criteria and product configuration preferences.
• Desk Research: Data collection phases aggregated hospital surgical procedure databases, group purchasing organization contract awards, and surgical device regulatory clearance databases from FDA, CE, and national regulatory authorities.
• Market-Sizing and Forecasting: Baseline values derive from a bottom-up aggregation of surgical procedure volumes by type, applying needle-suture utilization rates per procedure and regional pricing to project future revenue.
• Data Validation and Update Cycle: Projections are tested against publicly reported wound closure product revenue from leading surgical consumables manufacturers.

Why is the Absorbable Surgical Suture with Needle Market Growing?

Market expansion is being supported by the increasing global demand for efficient surgical solutions and the corresponding shift toward high-performance suture materials that can provide superior clinical characteristics while meeting surgeon requirements for tissue compatibility and cost-effective wound management processes. Modern healthcare providers are increasingly focused on incorporating suture systems that can enhance procedural outcomes while satisfying demands for consistent, precisely controlled healing patterns and optimized patient safety practices. Absorbable surgical sutures' proven ability to deliver clinical excellence, tissue integration, and diverse application possibilities makes them essential components for surgical teams and quality-conscious medical professionals.

The growing emphasis on minimally invasive procedures and surgical optimization is driving demand for high-performance suture systems that can support distinctive clinical outcomes and comprehensive tissue healing across general surgery, orthopedic procedures, and specialty surgical applications. Surgeon preference for sutures that combine clinical excellence with operational flexibility is creating opportunities for innovative implementations in both traditional and emerging surgical applications. The rising influence of robotic surgical processes and advanced medical technologies is also contributing to increased adoption of specialized suture materials that can provide authentic performance benefits and reliable clinical characteristics.

Segmental Analysis

The absorbable surgical suture with needle market is segmented by product type, application, material composition, needle type, absorption period, and region. By product type, the absorbable surgical suture with needle market is divided into monofilament sutures, braided sutures, barbed sutures, and others. Based on application, the absorbable surgical suture with needle market is categorized into hospital procedures, clinic procedures, ambulatory surgical centers, emergency care, and others. By material composition, the absorbable surgical suture with needle market includes polyglycolic acid, polylactic acid, polyglactin, polydioxanone, and composite materials.

By needle type, the absorbable surgical suture market encompasses cutting needles, tapered needles, reverse cutting needles, and specialized needles. By absorption period, the absorbable surgical suture with needle market includes short-term absorption (7-14 days), medium-term absorption (2-4 weeks), and long-term absorption (6-12 weeks). Regionally, the absorbable surgical suture with needle market is divided into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and other regions.

By Product Type, the Monofilament Sutures Segment Accounts for 52.3% Market Share

The monofilament sutures segment is projected to account for 52.3% of the absorbable surgical suture with needle market in 2026, reaffirming its position as the leading product category. Surgeons and medical professionals increasingly utilize monofilament sutures for their superior handling characteristics, established biocompatibility standards, and essential functionality in diverse surgical applications across multiple procedure types. Monofilament sutures' proven performance characteristics and established clinical effectiveness directly address surgeon requirements for reliable tissue integration and optimal wound healing precision in medical applications.

This product segment forms the foundation of modern surgical suturing patterns, as it represents the suture category with the greatest clinical impact potential and established compatibility across multiple surgical specialties. Medical investments in advanced polymer technology and performance optimization continue to strengthen adoption among quality-conscious healthcare providers. With surgeons prioritizing tissue compatibility and healing reliability, monofilament sutures align with both clinical objectives and safety requirements, making them the central component of comprehensive surgical strategies.

By Application, Hospital Procedures Segment Shows Strong Market Dominance

Hospital procedures is projected to represent 41.7% of the absorbable surgical suture with needle market in 2026, underscoring its critical role as the primary application for quality-focused medical facilities seeking superior surgical efficiency benefits and enhanced patient outcome credentials. Surgeons and hospital systems prefer hospital applications for their established procedure volumes, proven clinical demand, and ability to maintain exceptional healing quality while supporting versatile surgical requirements during diverse medical procedures. Positioned as essential applications for performance-conscious healthcare providers, hospital offerings provide both clinical excellence and competitive positioning advantages.

The segment is supported by continuous improvement in surgical technology and the widespread availability of established medical standards that enable quality assurance and premium positioning at the hospital level. The healthcare systems are optimizing suture selections to support procedure differentiation and competitive care strategies. As surgical technology continues to advance and medical professionals seek efficient wound closure methods, hospital applications will continue to drive market growth while supporting clinical development and patient satisfaction strategies.

What are the Drivers, Restraints, and Key Trends of the Absorbable Surgical Suture with Needle Market?

The absorbable surgical suture with needle market is advancing rapidly due to increasing surgical efficiency consciousness and growing need for precision medical solutions that emphasize superior clinical outcomes across hospital segments and surgical applications. The absorbable surgical suture with needle market faces challenges, including competition from alternative closure technologies, sterilization complexities, and material cost pressures affecting healthcare economics. Innovation in biocompatible materials integration and advanced manufacturing continues to influence market development and expansion patterns.

Expansion of Minimally Invasive Surgery Applications

The growing adoption of absorbable surgical sutures with needle in minimally invasive procedures and robotic surgery is enabling surgeons to develop surgical strategies that provide distinctive clinical benefits while commanding competitive positioning and enhanced patient outcome characteristics. Minimally invasive applications provide superior healing consistency while allowing more sophisticated tissue integration features across various surgical categories. Medical professionals are increasingly recognizing the clinical advantages of suture positioning for premium wound closure outcomes and efficiency-conscious procedure integration.

Integration of Advanced Polymer Technology and Biocompatible Materials

Modern absorbable surgical suture manufacturers are incorporating advanced polymer formulations, biocompatible coatings, and controlled absorption mechanisms to enhance clinical precision, improve tissue integration, and meet medical demands for intelligent wound closure solutions. These systems improve surgical effectiveness while enabling new applications, including infection prevention protocols and enhanced healing optimization programs. Advanced material integration also allows surgeons to support clinical leadership positioning and quality assurance beyond traditional suturing operations.

Analysis of the Absorbable Surgical Suture with Needle Market by Key Country

Country	CAGR (2026-2036)
China	9.3%
India	8.6%
Germany	7.9%
Brazil	7.2%
USA	6.6%
UK	5.9%
Japan	5.2%

Source: FMI analysis based on primary research and proprietary forecasting model

The absorbable surgical suture with needle market is experiencing robust growth globally, with China leading at a 9.3% CAGR through 2036, driven by the expanding healthcare infrastructure, growing surgical procedure volumes, and increasing adoption of advanced medical technologies. India follows at 8.6%, supported by rising medical tourism, expanding hospital systems, and growing acceptance of quality surgical solutions. Germany shows growth at 7.9%, emphasizing established healthcare capabilities and comprehensive medical technology development. Brazil records 7.2%, focusing on healthcare expansion and medical infrastructure growth. The USA demonstrates 6.6% growth, prioritizing advanced surgical technologies and clinical optimization.

The report covers an in-depth analysis of 40+ countries, Top-performing countries are highlighted below.

China Leads Global Market Growth with Healthcare Expansion

Revenue from absorbable surgical suture with needle consumption and sales in China is projected to exhibit exceptional growth with a CAGR of 9.3% through 2036, driven by the country's rapidly expanding healthcare sector, favorable government policies toward medical infrastructure development, and initiatives promoting advanced surgical technologies across major medical regions. China's position as a leading medical manufacturing hub and increasing focus on quality healthcare systems are creating substantial demand for high-quality absorbable surgical sutures in both domestic and international markets. Major hospital systems and surgical centers are establishing comprehensive suture capabilities to serve growing demand and emerging medical opportunities.

• Established healthcare development culture and expanding medical practices are driving demand for absorbable surgical sutures with needle across hospital procedures, surgical facilities, and comprehensive medical systems throughout Chinese healthcare markets.
• Strong manufacturing infrastructure and technology adoption initiatives are supporting the rapid adoption of premium absorbable surgical sutures among quality-conscious medical professionals seeking to meet evolving clinical standards and efficiency requirements.

India Demonstrates Strong Market Potential with Medical Infrastructure Focus

Revenue from absorbable surgical suture with needle products in India is expanding at a CAGR of 8.6%, supported by rising healthcare investment, growing medical development, and expanding surgical capabilities. The country's developing medical sector and increasing clinical investment in advanced surgical technologies are driving demand for absorbable surgical sutures across both traditional and modern medical applications. International medical companies and domestic distributors are establishing comprehensive operational networks to address growing market demand for quality sutures and efficient surgical solutions.

• Rising medical investment and expanding healthcare activity are creating opportunities for absorbable surgical suture adoption across hospital operations, modern medical projects, and surgical companies throughout major Indian medical regions.
• Growing healthcare development initiatives and surgical technology advancement are driving the adoption of suture products and services among domestic medical professionals seeking to enhance their clinical capabilities and meet increasing efficiency demand.

Germany Maintains Market Leadership with Medical Excellence

The absorbable surgical suture with needle market in Germany is projected to grow at a CAGR of 7.9% through 2036, supported by the country's mature healthcare sector, established medical standards, and leadership in surgical technology. Germany's sophisticated medical infrastructure and strong support for advanced surgical systems are creating steady demand for both traditional and innovative suture varieties. Leading medical manufacturers and specialty distributors are establishing comprehensive operational strategies to serve both domestic markets and growing export opportunities.

• Advanced medical capabilities and established healthcare markets are driving demand for premium absorbable surgical sutures with needle across hospital facilities, specialty surgeons, and comprehensive medical companies seeking superior functionality profiles and technical innovation.
• Strong clinical excellence culture and medical leadership are supporting the adoption of innovative sutures among professionals prioritizing surgical reliability and clinical efficiency in medical applications.

Brazil Strengthens Position with Healthcare Growth

The absorbable surgical suture with needle market in Brazil is projected to grow at a CAGR of 7.2% through 2036, driven by the country's emphasis on healthcare expansion, medical development, and growing surgical capabilities. Brazilian surgeons and medical systems consistently seek clinical-grade sutures that enhance procedure efficiency and support operational excellence for both traditional and modern surgical applications. The country's position as a Latin American healthcare leader continues to drive innovation in specialized suture applications and medical equipment standards.

• Expanding healthcare culture and growing medical markets are driving demand for clinical absorbable surgical sutures with needle across hospital systems, medical providers, and healthcare-focused facilities seeking superior performance and distinctive surgical profiles.
• Increasing focus on procedure efficiency and clinical medical systems is supporting the adoption of specialty suture varieties among surgeons and distributors seeking authentic Brazilian medical products in regional markets with established quality expertise.

USA Anchors Growth with Technology Integration

The absorbable surgical suture with needle market in the USA is projected to grow at a CAGR of 6.6% through 2036, supported by the country's emphasis on surgical technology advancement, clinical optimization, and advanced automation integration requiring efficient suture solutions. American surgeons and medical users prioritize performance reliability and clinical precision, making specialized sutures essential components for both traditional and modern surgical applications. The country's comprehensive technology leadership and advancing medical patterns support continued market expansion.

• Advanced technology capabilities and growing precision surgery are driving demand for absorbable surgical sutures with needle across specialty applications, modern medical formats, and technology-integrated surgical programs serving domestic markets with increasing functionality requirements.
• Strong focus on clinical optimization and performance excellence is encouraging surgeons and distributors to adopt suture solutions that support efficiency objectives and meet American quality standards for surgical applications.

UK Maintains Steady Growth with Quality Focus

The absorbable surgical suture with needle market in the UK is projected to grow at a CAGR of 5.9% through 2036, supported by established medical standards, mature healthcare markets, and emphasis on surgical reliability across clinical and hospital sectors. British surgeons and medical professionals prioritize quality performance and clinical consistency, creating steady demand for premium suture solutions. The country's comprehensive market maturity and established medical practices support continued development in specialized applications.

• Established healthcare markets and mature medical industry are driving demand for quality absorbable surgical sutures with needle across hospital procedures, medical operations, and professional surgical companies throughout British medical regions.
• Strong emphasis on quality standards and clinical reliability is supporting the adoption of premium suture varieties among surgeons seeking proven performance and established quality credentials in surgical applications.

Japan Demonstrates Precision-Focused Growth

The absorbable surgical suture with needle industry in Japan is projected to grow at a CAGR of 5.2% through 2036, supported by the country's emphasis on precision manufacturing, quality excellence, and advanced technology integration requiring efficient suture solutions. Japanese medical professionals and healthcare users prioritize technical performance and manufacturing precision, making specialized sutures essential components for both traditional and modern surgical applications. The country's comprehensive quality leadership and advancing medical patterns support continued market expansion.

• Advanced manufacturing technology capabilities and growing precision surgery applications are driving demand for absorbable surgical sutures with needle across specialty medical applications, modern hospital formats, and technology-integrated surgical programs serving domestic markets with increasing quality requirements.
• Strong focus on technical precision and manufacturing excellence is encouraging medical professionals and distributors to adopt suture solutions that support quality objectives and meet Japanese precision standards for surgical applications.

Europe Market Split by Country

The Europe absorbable surgical suture with needle market is projected to grow from USD 161.2 million in 2026 to USD 287.8 million by 2036, recording a CAGR of 6.0% over the forecast period. Germany leads the region with a 38.4% share in 2026, moderating slightly to 37.9% by 2036, supported by its strong medical infrastructure and demand for premium, technically advanced surgical suture systems. The United Kingdom follows with 26.1% in 2026, easing to 25.7% by 2036, driven by a mature healthcare market and emphasis on surgical reliability and clinical optimization. France accounts for 15.8% in 2026, rising to 16.3% by 2036, reflecting steady adoption of advanced surgical solutions and clinical efficiency enhancement.

Italy holds 11.2% in 2026, expanding to 12.0% by 2036 as medical facility expansion and specialty surgical applications grow. Spain contributes 5.9% in 2026, growing to 6.2% by 2036, supported by expanding healthcare sector and medical modernization. The Nordic countries rise from 2.1% in 2026 to 2.3% by 2036 on the back of strong technology adoption and advanced surgical methodologies. BENELUX remains at 0.5% share across both 2026 and 2036, reflecting mature, efficiency-focused medical markets.

Competitive Landscape of the Absorbable Surgical Suture with Needle Market

The absorbable surgical suture with needle market is characterized by competition among established medical device manufacturers, specialized surgical component producers, and integrated healthcare solution companies. Companies are investing in precision manufacturing technologies, advanced polymer development systems, product innovation capabilities, and comprehensive distribution networks to deliver consistent, high-quality, and reliable absorbable surgical suture systems. Innovation in biocompatibility enhancement, absorption optimization, and application-specific product development is central to strengthening market position and healthcare provider satisfaction.

Johnson & Johnson leads the absorbable surgical suture with needle market with a strong focus on medical device innovation and comprehensive absorbable surgical suture solutions, offering clinical component systems with emphasis on manufacturing excellence and technological heritage. Ethicon LLC provides specialized surgical sutures with a focus on hospital market applications and clinical engineering networks. Medtronic delivers integrated medical solutions with a focus on healthcare positioning and operational efficiency. B. Braun specializes in comprehensive surgical equipment with an emphasis on precision applications. Peters Surgical focuses on comprehensive medical device accessories with advanced design and premium positioning capabilities.

Global Absorbable Surgical Suture with Needle Market - Stakeholder Contribution Framework

The success of absorbable surgical sutures with needle in meeting clinical surgical demands, surgeon-driven efficiency requirements, and performance integration will not only enhance patient care outcomes but also strengthen global medical device manufacturing capabilities. It will consolidate emerging regions' positions as hubs for efficient medical component production and align advanced economies with clinical surgical systems. This calls for a concerted effort by all stakeholders - governments, healthcare bodies, manufacturers, distributors, and investors. Each can be a crucial enabler in preparing the absorbable surgical suture with needle market for its next phase of growth.

How Governments Could Spur Local Production and Adoption?

• Targeted Incentives: Introduce medical manufacturing modernization subsidies for companies adopting advanced absorbable surgical suture production technologies in medical device manufacturing and healthcare regions, and production-linked incentives for facilities producing components for domestic consumption and export markets.
• Trade Agreements: Accelerate export growth through bilateral and multilateral agreements that classify absorbable surgical sutures under "precision medical devices," easing cross-border regulatory approvals and medical certifications.
• Facilitate Innovation: Establish Centers of Excellence for surgical technology innovation and medical component engineering. Fund R&D into efficient manufacturing systems, material optimization, and quality-standard integration for clinical surgical operations.

How Healthcare Bodies Could Support Market Development?

• Foster Connectivity: Constitute a global absorbable surgical suture consortium linking medical manufacturers, equipment suppliers, surgeons, and policymakers to align production targets with quality and clinical commitments.
• Promote Exports: Work with export councils to brand absorbable surgical sutures as premium, clinically engineered medical solutions. Facilitate medical conferences to connect healthcare innovators with global buyers in hospital, surgical, and medical sectors.
• Training Programs: Develop curricula on advanced medical manufacturing, material selection, quality control processes, and clinical optimization to prepare manufacturers and medical professionals for premium market opportunities.

How Distributors and Medical Industry Players Could Strengthen the Ecosystem?

• Drive Integration: Bundle absorbable surgical sutures with performance-focused marketing and efficiency messaging systems. Position precision medical components as part of holistic "surgical optimization solutions."
• Forge Partnerships: Collaborate with medical manufacturers and technology providers for joint R&D on suture applications, clinical enhancement initiatives, and global quality assurance for premium markets.

How Manufacturers Could Navigate the Shift?

• Capture Premium Markets: Leverage government incentives and rising efficiency demand to offer absorbable surgical sutures into growth markets where alternative medical components face performance and reliability challenges.
• Invest in Technology: Partner with technology providers to advance efficient manufacturing workflows, clinical-grade quality, and advanced production practices.
• Build Capabilities: Train technical staff and quality specialists to demonstrate absorbable surgical sutures' clinical advantages, repositioning medical relationships toward long-term supply partnerships.

Key Players in the Absorbable Surgical Suture with Needle Market

• Johnson & Johnson
• Ethicon LLC
• Medtronic
• B. Braun
• Peters Surgical
• DemeTech
• Internacional Farmaceutica
• Teleflex Medical
• Mani AD Surgical
• Lotus Surgicals
• Weigao Group
• Boston Scientific
• Smith & Nephew
• ConMed
• Zimmer Biomet

Scope of the Report

Metric	Value
Quantitative Units	USD 524.13 million to USD 1,021.45 million, at a CAGR of 6.9%
Market Definition	Pre-assembled wound closure devices combining absorbable polymer suture strands with permanently attached surgical needles across multiple polymer compositions and needle geometries.
Product Type Segmentation	Monofilament Sutures, Braided Sutures, Barbed Sutures, Others
Application Segmentation	Hospital Procedures, Clinic Procedures, Ambulatory Surgical Centers, Emergency Care, Others
Material Composition Segmentation	Polyglycolic Acid, Polylactic Acid, Polyglactin, Polydioxanone, Composite Materials
Needle Type Segmentation	Cutting Needles, Tapered Needles, Reverse Cutting Needles, Specialized Needles
Absorption Period Segmentation	Short-term Absorption, Medium-term Absorption, Long-term Absorption
Regions Covered	North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East & Africa
Countries Covered	India, Germany, Brazil, USA, UK, Japan, and 40 plus countries
Key Companies Profiled	Johnson & Johnson, Ethicon LLC, Medtronic, B. Braun, Peters Surgical, DemeTech, Teleflex Medical, Boston Scientific, Smith & Nephew, ConMed, Zimmer Biomet
Forecast Period	2026 to 2036
Approach	Bottom-up methodology starting with surgical procedure volumes, applying needle-suture utilization rates per procedure type and regional pricing dynamics.

Absorbable Surgical Suture with Needle Market by Segments

Product Type:

• Monofilament Sutures
• Braided Sutures
• Barbed Sutures
• Others

Application:

• Hospital Procedures
• Clinic Procedures
• Ambulatory Surgical Centers
• Emergency Care
• Others

Material Composition:

• Polyglycolic Acid
• Polylactic Acid
• Polyglactin
• Polydioxanone
• Composite Materials

Needle Type:

• Cutting Needles
• Tapered Needles
• Reverse Cutting Needles
• Specialized Needles

Absorption Period:

• Short-term Absorption (7-14 days)
• Medium-term Absorption (2-4 weeks)
• Long-term Absorption (6-12 weeks)

Region:

North America

• United States
• Canada
• Mexico

Europe

• Germany
• United Kingdom
• France
• Italy
• Spain
• Nordic Countries
• BENELUX
• Rest of Europe

Asia Pacific

• China
• India
• Japan
• South Korea
• Australia
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Rest of Latin America

Middle East & Africa

• Kingdom of Saudi Arabia
• United Arab Emirates
• South Africa
• Rest of Middle East & Africa

Other Regions

• Oceania
• Central Asia
• Other Markets

Bibliography

• World Health Organization. (2024). Global guidelines for the prevention of surgical site infection. WHO.
• USA Food and Drug Administration. (2024). Guidance: Absorbable surgical sutures with needle, premarket submissions. FDA.
• European Commission. (2024). Medical Device Regulation (MDR 2017/745): Implementation guidance for wound closure devices. EC.
• Ministry of Health and Family Welfare, Government of India. (2024). Ayushman Bharat Health Infrastructure Mission: Progress report. MoHFW.
• German Institute for Standardization. (2024). DIN EN 13170: Surgical sutures, specifications and test methods. DIN.
• Organisation for Economic Co-operation and Development. (2024). Health at a glance: Surgical volumes and outcomes. OECD.

This bibliography is provided for reader reference. The full Future Market Insights report contains the complete reference list with primary research documentation.